[18F]FLT PET for non-invasive monitoring of early response to gene therapy in experimental gliomas. (Q39690653)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20563754%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

title

[18F]FLT PET for non-invasive monitoring of early response to gene therapy in experimental gliomas (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20563754%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

0 references

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20563754%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

11

Wolf-Dieter Heiss

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20563754%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

8

Volker Hesselmann

1 reference

5 February 2020

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20563754%20AND%20SRC:MED&resulttype=core&format=json

Klaus Wienhard

10

object named as

Klaus Wienhard

1 reference

5 February 2020

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20563754%20AND%20SRC:MED&resulttype=core&format=json

Benedikt Rueckriem

5

object named as

Benedikt Rueckriem

1 reference

5 February 2020

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20563754%20AND%20SRC:MED&resulttype=core&format=json

Stefan Vollmar

6

object named as

Stefan Vollmar

1 reference

5 February 2020

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20563754%20AND%20SRC:MED&resulttype=core&format=json

author name string

Maria A Rueger

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20563754%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Mitra Ameli

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20563754%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Hongfeng Li

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20563754%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Norbert Galldiks

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20563754%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Cornel Fraefel

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20563754%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Andreas H Jacobs

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20563754%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

publication date

1 June 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20563754%20AND%20SRC:MED&resulttype=core&format=json

Molecular Imaging and Biology

5 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20563754%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20563754%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20563754%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

page(s)

547-557

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20563754%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s11307-010-0361-6

5 February 2020

exact match

0 references

cites work

Immediate post-radiotherapy changes in malignant glioma can mimic tumor progression

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0361-6

Malignant gliomas: MR imaging spectrum of radiation therapy- and chemotherapy-induced necrosis of the brain after treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0361-6

Imaging proliferation in vivo with [F-18]FLT and positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0361-6

Potential impact of [ 18 F]3'-deoxy-3'-fluorothymidine versus [ 18 F]fluoro-2-deoxy-d-glucose in positron emission tomography for colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0361-6

[18F]3'-deoxy-3'-fluorothymidine PET for the diagnosis and grading of brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0361-6

Dynamic small-animal PET imaging of tumor proliferation with 3'-deoxy-3'-18F-fluorothymidine in a genetically engineered mouse model of high-grade gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0361-6

Glioma proliferation as assessed by 3'-fluoro-3'-deoxy-L-thymidine positron emission tomography in patients with newly diagnosed high-grade glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0361-6

Improved herpes simplex virus type 1 amplicon vectors for proportional coexpression of positron emission tomography marker and therapeutic genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0361-6

Creation of drug-specific herpes simplex virus type 1 thymidine kinase mutants for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0361-6

Fast and robust registration of PET and MR images of human brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0361-6

Molecular imaging of gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0361-6

Basis of FLT as a cell proliferation marker: comparative uptake studies with [3H]thymidine and [3H]arabinothymidine, and cell-analysis in 22 asynchronously growing tumor cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0361-6

Comparisons of anti-human immunodeficiency virus activities, cellular transport, and plasma and intracellular pharmacokinetics of 3'-fluoro-3'-deoxythymidine and 3'-azido-3'-deoxythymidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0361-6

Predicting treatment response of malignant gliomas to bevacizumab and irinotecan by imaging proliferation with [18F] fluorothymidine positron emission tomography: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0361-6

Early changes in [18F]FLT uptake after chemotherapy: an experimental study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0361-6

Early detection of tumor response to chemotherapy by 3'-deoxy-3'-[18F]fluorothymidine positron emission tomography: the effect of cisplatin on a fibrosarcoma tumor model in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0361-6

A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0361-6

A phase 1-2 clinical trial of gene therapy for recurrent glioblastoma multiforme by tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir. GLI328 European-Canadian Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0361-6

Thymidine kinase gene therapy for human malignant glioma, using replication-deficient retroviruses or adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0361-6

Phase I study of adenoviral delivery of the HSV-tk gene and ganciclovir administration in patients with current malignant brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0361-6

Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0361-6

Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0361-6

Uncoupling of 2-fluoro-2-deoxyglucose transport and phosphorylation in rat hepatoma during gene therapy with HSV thymidine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0361-6

Imaging progress of herpes simplex virus type 1 thymidine kinase suicide gene therapy in living subjects with positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0361-6

3'-18F-fluoro-3'-deoxy-L-thymidine: a new tracer for staging metastatic melanoma?

21 January 2018

1 reference

12 December 2020

3-deoxy-3-[(18)F]fluorothymidine-positron emission tomography for noninvasive assessment of proliferation in pulmonary nodules.

1 reference

12 December 2020

CL1-SR39: A noninvasive molecular imaging model of prostate cancer suicide gene therapy using positron emission tomography

1 reference

12 December 2020

Monitoring tumor cell proliferation by targeting DNA synthetic processes with thymidine and thymidine analogs.

1 reference

12 December 2020

Kinetic analysis of 3'-deoxy-3'-18F-fluorothymidine in patients with gliomas.

1 reference

12 December 2020

3'-[18F]fluoro-3'-deoxythymidine ([18F]-FLT) as positron emission tomography tracer for imaging proliferation in a murine B-Cell lymphoma model and in the human disease.

1 reference

12 December 2020

Validation of FLT uptake as a measure of thymidine kinase-1 activity in A549 carcinoma cells.

1 reference

12 December 2020

Different regulation of thymidine kinase during the cell cycle of normal versus DNA tumor virus-transformed cells.

1 reference

12 December 2020

18F-fluoro-L-thymidine and 11C-methylmethionine as markers of increased transport and proliferation in brain tumors.

1 reference

12 December 2020

Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDG.

1 reference

12 December 2020

Validity of PET studies in brain tumors.

1 reference

12 December 2020

Monitoring antiproliferative responses to kinase inhibitor therapy in mice with 3'-deoxy-3'-18F-fluorothymidine PET.

1 reference

12 December 2020

10.1007/S11307-010-0361-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20563754%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference